• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human PDZ domain-containing protein GIPC2 (GIPC2)

ACP14498

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP14498 Target NameGIPC2
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-315Protein LengthFull length protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8TF65
Background Information
  • Uniprot Id

    Q8TF65

  • Target Species

    Human

  • Target Name

    GIPC2

  • Target Full Name

    PDZ domain-containing protein GIPC2

  • Target Subcellular Location

    Cytoplasm.

  • Target Protein Families

    GIPC family

  • Target Tissue Specificity

    Expressed at highest levels in ascending colon and at moderate levels in adult kidney. Expressed at low levels in adult pancreas and at very low levels in adult liver. Expression is down-regulated in several primary tumors, such as kidney, colon and recta

  • Target Synonyms

    GIPC 2; GIPC PDZ domain containing family; member 2 ; GIPC2; GIPC2_HUMAN; Likely ortholog of mouse semaF cytoplasmic domain associated protein 2; PDZ domain protein GIPC2; PDZ domain-containing protein GIPC2; SemaF cytoplasmic domain associated protein 2; Semaphorin cytoplasmic domain associated protein 2 ; SEMCAP 2; SEMCAP2

  • Target Background

    Enables identical protein binding activity. Located in extracellular exosome.

Inquire Recombinant Human PDZ domain-containing protein GIPC2 (GIPC2) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification